- do 5 november 2026
- vr 6 november 2026
- za 7 november 2026
- zo 8 november 2026
This leading scientific congress focuses entirely on the treatment and research of urological cancers. Various medical disciplines come together here to share clinical insights into prostate, bladder, and kidney cancer. The event attracts a global audience of urologists, oncologists, and radiotherapists striving for optimal patient care.
A unique multidisciplinary collaboration
Within oncological care, close collaboration between various medical specialties is of crucial importance. For eighteen years, this congress has been the platform where these specialists meet. The unique character of the event stems from the pooling of resources between the largest European associations for medical oncology, radiotherapy, and urology. Together, they ensure a high-quality and broadly oriented program.
Scientific progress and clinical practice
The four-day program offers an in-depth look at the latest scientific breakthroughs and how they can be applied in daily practice. Participants examine complex case studies and discuss innovative treatment methods such as immunotherapy, precision surgery, and advanced radiation techniques. The latest guidelines for early detection and the impact of imaging techniques are also extensively analyzed during interactive discussions and poster presentations.
Who is this conference intended for?
This meeting is specifically designed for medical professionals involved in the care of patients with urological tumors. This includes urologists, medical oncologists, radiation therapists, pathologists, and radiologists. Additionally, the conference is highly valuable for computational biologists, young researchers, and specialized nurses who wish to deepen their knowledge of urological oncology and build international networks.
